SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950133-05-005408
Filing Date
2005-12-01
Accepted
2005-12-01 15:29:11
Documents
1
Group Members
BIOTECH INVEST N.V.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G w15257sc13g.htm SC 13G 37151
  Complete submission text file 0000950133-05-005408.txt   39253
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: SC 13G | Act: 34 | File No.: 005-37954 | Film No.: 051237630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300
Business Address VODERGASSE 3 SWITZERLAND SCHAFFHAUSEN V8 CH-8300 411724 59 59
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000